Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15320 | 649 | 26.7 | 71% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1698 | 6155 | ENDOMETRIAL CANCER//ENDOMETRIAL CARCINOMA//POSTMENOPAUSAL BLEEDING |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ENDOMETRIAL HYPERPLASIA | Author keyword | 52 | 30% | 22% | 145 |
| 2 | ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA | Author keyword | 37 | 81% | 3% | 22 |
| 3 | ATYPICAL ENDOMETRIAL HYPERPLASIA | Author keyword | 27 | 65% | 4% | 26 |
| 4 | COMPLEX ATYPICAL HYPERPLASIA | Author keyword | 13 | 69% | 2% | 11 |
| 5 | PROGESTIN THERAPY | Author keyword | 11 | 65% | 2% | 11 |
| 6 | SIMPLE ENDOMETRIAL HYPERPLASIA | Author keyword | 9 | 83% | 1% | 5 |
| 7 | ENDOMETRIAL ATYPICAL HYPERPLASIA | Author keyword | 7 | 67% | 1% | 6 |
| 8 | FERTILITY SPARING TREATMENT | Author keyword | 6 | 50% | 1% | 9 |
| 9 | EIN | Author keyword | 5 | 55% | 1% | 6 |
| 10 | FERTILITY SPARING THERAPY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | WELL DIFFERENTIATED CARCINOMA | 97 | 77% | 10% | 65 |
| 2 | FERTILITY SPARING TREATMENT | 33 | 77% | 4% | 23 |
| 3 | PRESERVING TREATMENT | 27 | 83% | 2% | 15 |
| 4 | FERTILITY PRESERVING TREATMENT | 25 | 77% | 3% | 17 |
| 5 | WOMEN 40 YEARS | 25 | 65% | 4% | 24 |
| 6 | MORPHOMETRICAL FEATURES | 21 | 90% | 1% | 9 |
| 7 | WOMEN 45 YEARS | 17 | 68% | 2% | 15 |
| 8 | ATYPICAL HYPERPLASIA | 16 | 24% | 9% | 57 |
| 9 | PRECANCERS | 13 | 36% | 4% | 29 |
| 10 | CURETTAGE SPECIMENS | 8 | 100% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review | 2012 | 38 | 51 | 94% |
| Hysteroscopic Resection in the Management of Early-stage Endometrial Cancer: Report of 2 Cases and Review of the Literature | 2015 | 1 | 16 | 88% |
| Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis | 2014 | 5 | 33 | 82% |
| Conservative treatment of early endometrial cancer | 2013 | 9 | 20 | 90% |
| Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls | 2012 | 15 | 24 | 71% |
| Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature | 2012 | 13 | 48 | 69% |
| Endometrial hyperplasia and the risk of progression to carcinoma | 2009 | 30 | 55 | 60% |
| Fertility-preserving treatment and pregnancy outcomes in the early stage of endometrial carcinoma | 2013 | 3 | 47 | 98% |
| Fertility-Sparing Therapy in Young Women With Endometrial Cancer 2010 Update | 2010 | 13 | 86 | 80% |
| A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer | 2009 | 24 | 18 | 61% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GANGNAM CHA MED | 3 | 32% | 1.1% | 7 |
| 2 | GRP GYNAECOL CANC | 1 | 100% | 0.3% | 2 |
| 3 | HOP ALIX CHAMPAGNE | 1 | 100% | 0.3% | 2 |
| 4 | PRACOWNIA MENOPAUZY ANDROPAUZY | 1 | 40% | 0.3% | 2 |
| 5 | BIOCHEM PATHOMORPHOL | 1 | 50% | 0.2% | 1 |
| 6 | CHAIR GYNECOL OBSTET GYNECOL ONCOL | 1 | 50% | 0.2% | 1 |
| 7 | CLIN SURG CANC WOMENS DIS | 1 | 50% | 0.2% | 1 |
| 8 | ENDOSCOP GYNECOL UNIT | 1 | 50% | 0.2% | 1 |
| 9 | GYNAKOPATHOL | 1 | 50% | 0.2% | 1 |
| 10 | GYNECOL SPECIALITIES | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000217946 | NUTR HORMONES UNIT//ENDOMETRIAL CANCER RISK//ENDOMETRIAL NEOPLASMS |
| 2 | 0.0000203892 | ENDOMETRIAL CANCER//ENDOMETRIAL CARCINOMA//UTERINE PAPILLARY SEROUS CARCINOMA |
| 3 | 0.0000195296 | POSTMENOPAUSAL BLEEDING//HYSTEROSCOPY//ENDOMETRIAL POLYPS |
| 4 | 0.0000118778 | SUBJEFATURA INVEST BIOMED//UNIDAD INVEST MED BIOL REPROD//COLPOSCOPIA |
| 5 | 0.0000079189 | PRIMARY SQUAMOUS CELL CARCINOMA OF THE ENDOMETRIUM//ICHTHYOSIS UTERI//ENDOMETRIAL AND OVARIAN CARCINOMAS |
| 6 | 0.0000071816 | TUMOR CLONALITY//CLONAL REMISSION//M27 BETA |
| 7 | 0.0000066204 | ENDOMETRIAL ABLATION//MENORRHAGIA//HEAVY MENSTRUAL BLEEDING |
| 8 | 0.0000051902 | MULTIPLE PRIMARY MALIGNANCIES//MULTIPLE PRIMARY MALIGNANT NEOPLASMS//MULTIPLE PRIMARY NEOPLASMS |
| 9 | 0.0000051535 | ATYPICAL GLANDULAR CELLS//ADENOMA MALIGNUM//ADENOCARCINOMA IN SITU |
| 10 | 0.0000051261 | PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A |